◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksH › HUM

Humana Inc (HUM) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · Managed Health Care · DATA UPDATED 2026-09-13

Humana Inc (HUM) operates in the Managed Health Care industry and is headquartered in Louisville, United States with about 67,060 employees. Its market capitalization is roughly $46 billion. In the fiscal year ended 2025-12-31, HUM reported $129.7B in revenue and $1.2B in net income.

Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell.

Interactive charts & full statements → Open the HUM valuation workbench →

HUM Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Revenue$145.7B$129.7B$117.8B$106.4B$92.9B$83.6B$77.2B$64.9B$56.9B$53.8B$54.4B$54.3B$48.5B$41.3B$39.1B$36.8B$33.9B$31.0B$29.0B$25.3B$21.4B
Gross Profit$19.9B$18.9B$17.1B$18.0B$17.2B$14.4B$15.7B$11.2B$11.2B$7.1B$7.8B$7.8B$8.0B$6.7B$6.1B$5.7B$4.8B$4.5B$4.2B$3.7B$3.2B
Gross Margin %13.7%14.5%14.5%17.0%18.5%17.3%20.3%17.2%19.7%13.2%14.3%14.3%16.4%16.2%15.7%15.4%14.1%14.5%14.3%14.5%14.8%
Operating Income (EBIT)$2.0B$1.5B$1.6B$3.3B$3.6B$3.4B$4.7B$3.5B$2.1B$3.3B$1.7B$2.3B$2.4B$2.1B$2.1B$2.3B$2.0B$1.7B$1.2B$1.4B$825M
Operating Margin %1.4%1.1%1.4%3.1%3.8%4.1%6.1%5.3%3.6%6.2%3.2%4.3%4.9%5.0%5.3%6.4%6.0%5.5%4.0%5.4%3.9%
Net Income$1.3B$1.2B$1.2B$2.5B$2.8B$2.9B$3.4B$2.7B$1.7B$2.4B$614M$1.3B$1.1B$1.2B$1.2B$1.4B$1.1B$1.0B$647M$834M$487M
Net Margin %0.9%0.9%1.0%2.3%3.0%3.5%4.4%4.2%3.0%4.5%1.1%2.4%2.4%3.0%3.1%3.9%3.2%3.4%2.2%3.3%2.3%
EBITDA$3.1B$2.9B$3.3B$4.7B$4.8B$4.5B$5.6B$4.3B$2.8B($936M)$2.2B($270M)$2.8B$2.5B$46M$2.6B$162M$2.0B$103M$1.5B$974M
Earnings Per Share (EPS)$10.56$9.83$9.99$20.00$22.08$22.67$25.31$20.09$12.16$16.81$4.07$8.44$7.36$7.73$7.48$8.46$6.47$6.15$3.83$4.91$2.90
Shares Outstanding (M)121M121M121M124M127M129M133M135M138M146M151M151M156M159M163M168M170M169M169M170M168M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

HUM Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Total Revenue$40.9B$39.6B$32.5B$32.6B$32.4B$32.1B$29.2B$29.4B
Gross Profit$5.5B$5.9B$3.8B$4.7B$4.8B$5.6B$3.8B$4.3B
Gross Margin %13.5%15.0%11.7%14.3%14.9%17.4%13.1%14.5%
Operating Income (EBIT)$1.4B$1.6B($1.0B)$108M$722M$1.6B($899M)$635M
Operating Margin %3.3%4.0%-3.1%0.3%2.2%5.1%-3.1%2.2%
Net Income$693M$1.2B($796M)$195M$545M$1.2B($693M)$480M
Net Margin %1.7%3.0%-2.5%0.6%1.7%3.9%-2.4%1.6%
EBITDA$1.3B$2.0B($685M)$480M$1.1B$2.0B($495M)$1.0B
Earnings Per Share (EPS)$5.73$9.83$-6.61$1.61$4.51$10.30$-5.74$3.97
Shares Outstanding (M)121M121M120M121M121M121M121M121M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

HUM Free Cash Flow History

Cash flowTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Cash from Operations (CFO)$147M$921M$3.0B$4.0B$4.6B$2.3B$5.6B$5.3B$2.2B$4.1B$1.9B$868M$1.6B$1.7B$1.9B$2.1B$2.2B$1.4B$982M$1.2B$1.7B
Capital Expenditures (CapEx)$590M$546M$575M$1.0B$1.1B$1.3B$964M$736M$612M$526M$527M$523M$528M$437M$410M$336M$222M$185M$262M$239M$193M
Free Cash Flow (FCF)($443M)$375M$2.4B$3.0B$3.5B$946M$4.7B$4.5B$1.6B$3.5B$1.4B$345M$1.1B$1.3B$1.5B$1.7B$2.0B$1.2B$721M$985M$1.5B
FCF Margin %-0.3%0.3%2.0%2.8%3.7%1.1%6.1%7.0%2.7%6.6%2.6%0.6%2.2%3.1%3.9%4.7%6.0%4.0%2.5%3.9%7.0%
Dividends Paid$430M$430M$431M$431M$392M$354M$323M$291M$265M$220M$177M$172M$172M$168M$165M$82M$0M$0M$2.4B$95M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

HUM Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Cash from Operations (CFO)($426M)$1.3B($1.7B)$971M$1.3B$331M($528M)$1.9B
Capital Expenditures (CapEx)$132M$121M$202M$135M$114M$95M$154M$130M
Free Cash Flow (FCF)($558M)$1.1B($1.9B)$836M$1.2B$236M($682M)$1.7B
FCF Margin %-1.4%2.9%-5.7%2.6%3.6%0.7%-2.3%5.9%
Dividends Paid$107M$107M$109M$107M$106M$108M$108M$107M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

HUM Balance Sheet History

Balance sheet2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Assets$57.2B$48.8B$46.3B$46.9B$43.7B$44.7B$35.1B$29.0B$25.3B$26.7B$25.8B$25.1B$23.4B$20.8B$19.5B$17.9B$16.1B$14.2B$13.0B$12.9B$10.1B
Cash & Cash Equivalents$6.9B$4.2B$2.2B$4.7B$5.1B$3.4B$4.7B$4.1B$2.3B$4.0B$3.9B$2.6B$1.9B$1.1B$1.3B$1.4B$1.7B$1.6B$2.0B$2.0B$1.7B
Total Liabilities$37.9B$31.0B$29.9B$30.6B$28.4B$28.6B$21.3B$17.0B$15.2B$16.8B$15.1B$14.8B$13.8B$11.5B$10.7B$9.8B$9.1B$8.4B$8.6B$8.8B$7.1B
Total Debt (Short + Long-Term)$14.2B$12.5B$11.9B$11.8B$11.3B$12.7B$6.8B$5.8B$6.1B$4.9B$4.4B$4.1B$4.2B$3.0B$2.9B$2.0B$1.7B$2.1B$2.2B$2.0B$1.6B
Total Shareholders' Equity$19.2B$17.7B$16.4B$16.3B$15.3B$16.1B$13.7B$12.0B$10.2B$9.8B$10.7B$10.3B$9.6B$9.3B$8.8B$8.1B$6.9B$5.8B$4.5B$4.0B$3.1B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive HUM viewer.

HUM Metric Deep Dives

Other Companies in Managed Health Care

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← HULLAll “H” companiesHUMA →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.